Tradestie Institutional Equity Comparison Engine

UFPT vs UTMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

UTMD Overall Edge

UTMD Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Utah Medical Products Inc (UTMD) driven by superior Valuation, Growth & Margin, Momentum & Technical while UFPT counters with relative strength in Options & Structure. Fundamentally, UFPT trades at 24.7x Forward P/E with 15.4% operating margin (+11.6% YoY revenue) versus UTMD at 13.0x Forward P/E and 34.3% operating margin (-12.1% YoY). In options structure, UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro) against UTMD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner UTMD
UFPT 24.7x vs UTMD 13.0x Fwd P/E
Growth & Margin Winner UTMD
Op Margin 15.4% vs 34.3% ยท YoY +11.6% vs -12.1%
Momentum & Technical Winner UTMD
1Y +27.4% vs +29.0% ยท 52W Pos 74% vs 80%
Options & Structure Winner UFPT
UNCLASSIFIED (3rd %ile IV) vs UNCLASSIFIED (N/A IV)
UFPT NASDAQ
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap $2.4B
1M Return +2.36%
1Y Return +27.42%
Forward P/E 24.7x
Unified AI Score
42.6 / 100 HOLD
Tech 25.0 Fund 37.0 Flow 50.0 Mom 40.0
UTMD NASDAQ
Utah Medical Products Inc
Surgical & Medical Instruments & Apparatus
$72.36
+0.54% 1D
Market Cap $204.9M
1M Return -2.89%
1Y Return +28.96%
Forward P/E 13.0x
Unified AI Score
52.9 / 100 HOLD
Tech 46.0 Fund 49.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UFPT +27.42% UTMD +28.96% Spread: +1.54 pp (UTMD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UFPT TTM Op. Margin: 15.4% UTMD TTM Op. Margin: 34.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UFPT vs UTMD. Trailing 12-month operating profitability (UFPT 15.4% vs UTMD 34.3%) and valuation multiples (UFPT 24.7x vs UTMD 13.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UFPT (3) vs UTMD (7)
Institutional Metric UFPT UTMD Criterion Row Winner
Market Capitalization Scale $2.4B $204.9M Larger Scale UFPT
Trailing P/E Ratio Valuation 31.2x 21.6x Lower Multiple UTMD
Forward P/E Ratio Valuation 24.7x 13.0x Lower Multiple UTMD
Revenue Growth (YoY) Growth +11.6% -12.1% Higher Growth UFPT
Operating Margin (TTM) Profitability 15.4% 34.3% Higher Margin UTMD
Net Profit Margin Profitability 11.8% 30.5% Higher Margin UTMD
Return on Equity (ROE) Capital Efficiency 17.2% 8.8% Higher ROE UFPT
52-Week Range Position Momentum 74% ($174โ€“$342) 80% ($54โ€“$77) Stronger Trend UTMD
Beta / 30D Volatility Risk Regime 1.64ฮฒ ยท 77% Vol 0.23ฮฒ ยท 33% Vol Lower Realized Risk UTMD
Unified Institutional Score Composite Signal 42.6 / 100 (HOLD) 52.9 / 100 (HOLD) Higher Composite UTMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UFPT vs UTMD Buy Guide
UFPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live UFPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UTMD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UTMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UFPT nor UTMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.